These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15914575)

  • 1. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
    Song GH; Leng PH; Gwee KA; Moochhala SM; Ho KY
    Gut; 2005 Oct; 54(10):1402-7. PubMed ID: 15914575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study.
    Faghih Dinevari M; Jafarzadeh F; Jabbaripour Sarmadian A; Abbasian S; Nikniaz Z; Riazi A
    BMC Gastroenterol; 2023 Apr; 23(1):135. PubMed ID: 37098505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: a randomized double-blinded placebo study.
    Wong RK; Yang C; Song GH; Wong J; Ho KY
    Dig Dis Sci; 2015 Jan; 60(1):186-94. PubMed ID: 25092036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study.
    Lu WZ; Gwee KA; Moochhalla S; Ho KY
    Aliment Pharmacol Ther; 2005 Nov; 22(10):927-34. PubMed ID: 16268966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
    Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
    Wouters MM; Balemans D; Van Wanrooy S; Dooley J; Cibert-Goton V; Alpizar YA; Valdez-Morales EE; Nasser Y; Van Veldhoven PP; Vanbrabant W; Van der Merwe S; Mols R; Ghesquière B; Cirillo C; Kortekaas I; Carmeliet P; Peetermans WE; Vermeire S; Rutgeerts P; Augustijns P; Hellings PW; Belmans A; Vanner S; Bulmer DC; Talavera K; Vanden Berghe P; Liston A; Boeckxstaens GE
    Gastroenterology; 2016 Apr; 150(4):875-87.e9. PubMed ID: 26752109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome.
    Patel A; Hasak S; Cassell B; Ciorba MA; Vivio EE; Kumar M; Gyawali CP; Sayuk GS
    Aliment Pharmacol Ther; 2016 Aug; 44(3):246-58. PubMed ID: 27240555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin: a novel treatment for IBS?
    Elsenbruch S
    Gut; 2005 Oct; 54(10):1353-4. PubMed ID: 16162946
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial.
    Leighton MP; Lam C; Mehta S; Spiller RC
    Trials; 2013 Jan; 14():10. PubMed ID: 23302220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study.
    Kuiken SD; Tytgat GN; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2003 May; 1(3):219-28. PubMed ID: 15017494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.
    Lacy BE; Chang L; Rao SSC; Heimanson Z; Sayuk GS
    Clin Ther; 2023 Mar; 45(3):198-209. PubMed ID: 36922331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary study of melatonin in irritable bowel syndrome.
    Saha L; Malhotra S; Rana S; Bhasin D; Pandhi P
    J Clin Gastroenterol; 2007 Jan; 41(1):29-32. PubMed ID: 17198061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin for the treatment of irritable bowel syndrome.
    Siah KT; Wong RK; Ho KY
    World J Gastroenterol; 2014 Mar; 20(10):2492-8. PubMed ID: 24627586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloating and distention in irritable bowel syndrome: the role of visceral sensation.
    Agrawal A; Houghton LA; Lea R; Morris J; Reilly B; Whorwell PJ
    Gastroenterology; 2008 Jun; 134(7):1882-9. PubMed ID: 18455167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep measures predict next-day symptoms in women with irritable bowel syndrome.
    Buchanan DT; Cain K; Heitkemper M; Burr R; Vitiello MV; Zia J; Jarrett M
    J Clin Sleep Med; 2014 Sep; 10(9):1003-9. PubMed ID: 25142761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women.
    Chojnacki C; Walecka-Kapica E; Lokieć K; Pawłowicz M; Winczyk K; Chojnacki J; Klupińska G
    Endokrynol Pol; 2013; 64(2):114-20. PubMed ID: 23653274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P; Acalovschi M; Triantafillidis JK; Uspensky YP; Kalayci C; Shee V; Tack J;
    Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW;
    PLoS Med; 2018 Jun; 15(6):e1002587. PubMed ID: 29912983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for altered anorectal function in irritable bowel syndrome patients with sleep disturbance.
    Chen CL; Liu TT; Yi CH; Orr WC
    Digestion; 2011; 84(3):247-51. PubMed ID: 21952561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
    Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D
    Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.